Rockland Immunochemicals Awarded Phase II SBIR Funding

News   Oct 16, 2012

 
Rockland Immunochemicals Awarded Phase II SBIR Funding
 
 
 

RELATED ARTICLES

Stem Cell Signaling Drives Mammary Gland Development

News

New research illuminates the biology of breast tissue development and may pave the way to new strategies for diagnosing or even treating cancer.

READ MORE

Inflammatory Bowel Disease Linked with Common Bacterial Gut Toxin

News

New research has uncovered a surprise link between a common bacterial toxin found in the gut and inflammatory bowel disease (IBD). It shows that breakdown products from the toxin seem to trigger gut inflammation that is characteristic of IBD.

READ MORE

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE